JEAN-LOUIS CONSTANZA

WANDERCRAFT

Jean-Louis Constanza is one of the founders, and Chief Clinical and Development Officer, of Wandercraft. In the last 5 years he worked with many medical teams to adapt Wandercraft’s exo, the first autonomous walk robotic exoskeleton, to the needs of Neuro and PMR institutions and their patients. He has a 30 years experience in digital and robotics industries and start-ups.

dont miss

Autonomous Walk Exoskeleton: first learnings from clinical trials and expectations

The first autonomous walk exoskeleton has been tested since 2017 and is now being used for patient treatment in Europe. The seminar aim is to present and discuss preliminary learnings, on-going clinical studies and expected impact on treatment for stroke patients and patients with severe gait disorder.

EVEN MORE SEMINARS

  • Rosanne Tyas: Speaking at the European Neurological Convention

    Rosanne Tyas
    Royal Hospital for Neuro-disability

    Music Therapy has much to offer: An overview of the effects of music therapy across different domains in neuro-disability.

  • Dr Jenny Brooks: Speaking at the European Neurological Convention

    Dr Jenny Brooks
    The ABI Team

    Neurobehavioural Rehabilitation In The Community

  • Dr Najma Khan-Bourne: Speaking at the European Neurological Convention

    Dr Najma Khan-Bourne
    King’s College Hospital NHS Foundation Trust

    Neuropsychological evaluation and formulation in acute stroke rehabilitation

  • Dr Nick Davis: Speaking at the European Neurological Convention

    Dr Nick Davis
    Manchester Metropolitan University

    Towards precision treatment and enhancement with non-invasive brain stimulation

  • Shauna Kearney: Speaking at the European Neurological Convention

    Shauna Kearney
    Birmingham Children’s Hospital

    The neuropsychology of Inherited metabolic disorders